mRNA Cancer Vaccine Slashes Melanoma Return in 1,137 Patients

A personalized cancer treatment using the same technology behind COVID vaccines just proved it can significantly reduce melanoma recurrence in the largest trial of its kind.

Experts are calling it a breakthrough that could transform how we fight cancer.